

01 Nov 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/antengene-granted-ind-approval-in-china-for-the-phase-ib-study-of-atg-008-onatasertib-in-combination-with-atg-010-selinexor-in-patients-with-diffuse-large-b-cell-lymphoma-301413468.html